Skip to content

Maria González

2 papers in the library · 144 citations · publishing 2021-2024

Papers

Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

Psychopharmacology January 11, 2021 Nicole Leite Galvão‐coelho, Wolfgang Marx, Maria González et al. 143 citations

Classic serotonergic psychedelics such as psilocybin, LSD, and ayahuasca may improve mood and reduce depressive symptoms more than placebo, with effects appearing within hours and lasting up to 60 days. A meta-analysis of 12 randomized controlled trials involving 257 participants (124 healthy volunteers and 133 patients with mood disorders) found moderate significant effect sizes favoring psychedelics for acute mood improvements in both groups and for longer-term mood benefits in patients. For patients with mood disorders, significant reductions in depressive symptoms were seen acutely, at 2–7 days, and at 16–60 days after treatment. Although unblinding and expectancy are concerns, the strength, speed, and durability of effects support further placebo-controlled trials.

Evaluation of a group intervention based on Mindfulness in patients with anxiety and depression cared for in mental health community center: a quasy-experimental study.

Enfermeria clinica January 1, 2024 Clara Fort-Rocamora, Rocío Casañas, Ana Torres-Torres et al. 1 citation

A group mindfulness program for adults with anxiety and depression at a community mental health center led to improvements in anxiety, depressive symptoms, and overall quality of life. The study included 128 patients, mostly women with an average age of 52. Participants attended a mean of 6 out of 9 weekly sessions. Greater attendance was linked to larger reductions in anxiety and depression. No differences in outcomes were found across age groups.